These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 4303244)

  • 21. SV40 neutralizing antibodies in the sera of man and experimental animals.
    Horváth LB
    Acta Virol; 1972 Mar; 16(2):141-6. PubMed ID: 4401071
    [No Abstract]   [Full Text] [Related]  

  • 22. [Synthesis of SV 40 tumor antigen in cells with inhibited cell division].
    Motejlovà A; Koza J; Matyàsovà I; Rampas J
    Cesk Epidemiol Mikrobiol Imunol; 1972; 21(6):287-92. PubMed ID: 4353673
    [No Abstract]   [Full Text] [Related]  

  • 23. Autologous antibodies to meningioma cell surface antigens.
    Pfreundschuh M; Röhrich M; Piotrowksi W; Penzholz H; Fischer H
    Anticancer Res; 1981; 1(6):367-72. PubMed ID: 6284017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Serological studies on the incidence of complement-fixing antibodies against cytomegalovirus in Westberlin].
    Henneberg G; Antoniadis G
    Zentralbl Bakteriol Orig; 1970 Apr; 213(3):416-27. PubMed ID: 4318515
    [No Abstract]   [Full Text] [Related]  

  • 25. [Serum SV40 T-antibodies in cerebral tumors of various types. Negative study in 84 subjects].
    Guillon F; Poissor M; Giraldo G; Beth E; Lorenzo A; Huraux JM
    Nouv Presse Med; 1981 Aug 29-Sep 5; 10(31):2584. PubMed ID: 6269047
    [No Abstract]   [Full Text] [Related]  

  • 26. [Detection of complement-fixing antibodies against herpes simplex virus in a sample of population from Accra (Ghana)].
    Russo V; D'Arrigo C
    Ann Med Nav (Roma); 1968; 73(3):213-7. PubMed ID: 4310529
    [No Abstract]   [Full Text] [Related]  

  • 27. [Levels of anti-nDNA using immunofluorescence on Crithidia luciliae. II. Prognostic value of complement-fixing anti-nDNA. Longitudinal study of 16 lupus disorders].
    Meyer O; Borda-Iriarte O; Cyna J; Haïm T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1984 May; 51(5):243-9. PubMed ID: 6377460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The content of serum anti-adenovirus antibodies in the healthy population].
    Topciu V; Moldovan E; Plavoşin-Babuşceac L; Csaky N; Radu M; Comşulea L
    Arch Roum Pathol Exp Microbiol; 1970 Sep; 29(3):463-9. PubMed ID: 4328574
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of SV40 to immunize against hepatitis B surface antigen: implications for the use of SV40 for gene transduction and its use as an immunizing agent.
    Kondo R; Feitelson MA; Strayer DS
    Gene Ther; 1998 May; 5(5):575-82. PubMed ID: 9797861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of antibodies to hepatitis E virus in residents of a district in Havana, Cuba.
    Quintana A; Sanchez L; Larralde O; Anderson D
    J Med Virol; 2005 May; 76(1):69-70. PubMed ID: 15779049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum antibodies to JC virus, BK virus, simian virus 40, and the risk of incident adult astrocytic brain tumors.
    Rollison DE; Helzlsouer KJ; Alberg AJ; Hoffman S; Hou J; Daniel R; Shah KV; Major EO
    Cancer Epidemiol Biomarkers Prev; 2003 May; 12(5):460-3. PubMed ID: 12750243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Spontaneously acquired anti-mumps immunity in children and adults].
    Drouhet V; Celers J
    Ann Pediatr (Paris); 1971 Apr; 18(4):272-6. PubMed ID: 5573999
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibodies to SV40 in sera from humans and macaques.
    Minor P; Pipkin PA
    Dev Biol (Basel); 2006; 123():99-107; discussion 119-32. PubMed ID: 16566439
    [No Abstract]   [Full Text] [Related]  

  • 34. [SV 40 T antigen].
    Yamaguchi N
    Tanpakushitsu Kakusan Koso; 1983 Apr; 28(4):306-12. PubMed ID: 6310700
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-GM-CSF antibodies in paediatric pulmonary alveolar proteinosis.
    Latzin P; Tredano M; Wüst Y; de Blic J; Nicolai T; Bewig B; Stanzel F; Köhler D; Bahuau M; Griese M
    Thorax; 2005 Jan; 60(1):39-44. PubMed ID: 15618581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus.
    Spear GT; Takefman DM; Sullivan BL; Landay AL; Jennings MB; Carlson JR
    Virology; 1993 Aug; 195(2):475-80. PubMed ID: 8337824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus and infectious mononucleosis in children.
    Tamir D; Ben-Porath E; Benderly A; Levy J; Strahovsky P
    Isr J Med Sci; 1983 Oct; 19(10):952-4. PubMed ID: 6319323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of cell membrane antigens using radioiodinated, purified antibodies. I. Solubilization and preliminary fractionation of membrane antigens of cells transformed by SV 40 virus.
    Kedar E; Aaronov A; Sulitzeanu D
    Isr J Med Sci; 1973 Mar; 9(3):266-76. PubMed ID: 4350974
    [No Abstract]   [Full Text] [Related]  

  • 39. [Viral profile of multiple sclerosis. Study of virus complement fixing antibodies].
    Daniel P
    Nouv Presse Med; 1972 Jul; 1(29):1939-42. PubMed ID: 4340874
    [No Abstract]   [Full Text] [Related]  

  • 40. Various antibody holding status against viruses in Cercopithecus aethiops and Macaca irus. II. The presence of neutralizing antibody against herpes virus, ECHO virus and simian virus 40.
    Nagashima T; Takada M; Yamane Y; Owada Y; Kasahara S
    Kitasato Arch Exp Med; 1967 Dec; 40(1):45-56. PubMed ID: 4303328
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.